Moderna sues Pfizer/BioNTech for patent infringement on COVID vaccine

Moderna’s logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration Join now for FREE unlimited access to Reuters.com Register Aug 26 (Reuters) – Moderna sued Pfizer and its German partner BioNTech on Friday for patent infringement in the development of the first COVID-19 vaccine approved … Read more

Full of money, Pfizer buys Global Blood Therapeutics for $5.4 billion

Aug 8 (Reuters) – Pfizer Inc on Monday agreed to pay $5.4 billion in cash to sickle cell drugmaker Global Blood Therapeutics (GBT.O)as it seeks to capitalize on an increase in revenue from its COVID-19 vaccine and treatment. Pfizer will pay $68.50 per GBT share, representing a 7.3% premium to its Friday closing price and … Read more

If you’re at high risk, don’t wait for updated COVID vaccines, experts say

CHICAGO, July 29 (Reuters) – People at high risk of severe illness who have not yet received a second COVID-19 booster should not wait for next-generation vaccines targeting Omicron due in the fall, five said vaccine experts at Reuters. In many countries, including the United States, the BA.5 Omicron subvariant of the virus is thriving, … Read more